Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder
Primary Sponsor
Urological Society of Australasia
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
67
Trial Chairperson
Dr Kumar Gogna, QRI Mater Centre, QLD
Trial Contact
Kumar Gogna
Clinical Trial Registration
Related Post
14 April, 2026
Consumer Engagement Charter cements TROG’s commitment to listen to consumer voices
LATEST NEWS: 14 April 2026 TROG has made a
9 April, 2026
Vale Professor Jim Denham OAM, TROG founder and world-class researcher
9 April 2026 TROG Cancer Research honours the life